(2R,3R,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)-4-methoxytetrahydrofuran-3-ol

Catalog No. :
ACGZRO241
CAS No. :
10300-22-8
Molecular Formula :
C11H15N5O4
Molecular Weight :
281.27

IUPAC Name:(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)-4-methoxytetrahydrofuran-3-ol

(2R,3R,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)-4-methoxytetrahydrofuran-3-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$102.00Login to see priceIn stockIn stock
5g97%$323.00Login to see priceIn stockIn stock
25g97%$1567.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,3R,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)-4-methoxytetrahydrofuran-3-ol
IUPAC Name(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)-4-methoxytetrahydrofuran-3-ol
MDL No.MFCD00057003
Molecular FormulaC11H15N5O4
Molecular Weight281.27
SMILESOC[C@@H]1[C@H]([C@H]([C@H](N2C=NC3=C2N=CN=C3N)O1)O)OC
InChI KeyRYAFZRROCNNRFK-IOSLPCCCSA-N
Synonym(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)-4-methoxyoxolan-3-ol | MFCD00057003 | 3'-o-methyl-d-adenosine | BS-50743 | (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)-4-methoxytetrahydrofuran-3-ol | SCHEMBL3369124 | BP-58838 | CHEB
CAS No.10300-22-8
PubChem CID82530

Synthetic Route by SureRoute

1. ACGZRO241 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGZRO241 route product structure diagram
    ACGZRO24110300-22-8 In Stock
Inquiry

2. ACGZRO241 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGZRO241 route product structure diagram
    ACGZRO24110300-22-8 In Stock
Inquiry

Comments (0)